Table 1.

Categories of ‘highest risk’ for ASCVD (around or above a benchmark of 30% 10-year risk) on statin therapy, based on published trial data

Category	Projected 10-year risk on moderate- or high-intensity statin therapy (%)
Clinical ASCVD + diabetes	28–38
No CKD	26–29
With CKD	28–43
Clinical ASCVD + CKD	34–35
Recent acute coronary syndrome (<3 months)	32
CHD and poorly controlled risk factors	28–41
CHD and peripheral vascular disease	43–55
CHD and age ≥65 years	21–54
Stroke/transient ischaemic attack and male	31
CHD and familial hypercholesterolaemia (baseline LDL-C ≥190 mg/dL)	41

ASCVD, atherosclerotic cardiovascular disease; CHD, coronary heart disease; CKD, chronic kidney disease.

Adapted from Robinson et al.²²